New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...